Changes in CTC burden and prevalence of specific CTC subtypes in mCRPC patients (pts) receiving alpharadin (Ra-223) as single agent or in combination with other therapuetics (Tx) Meeting Abstract


Authors: Dittamore, R. V.; Jendrisak, A.; Schreiber, N. A.; McLaughlin, B.; Graf, R.; Rodriguez, A.; Fleisher, M.; Lee, J.; Kelvin, J.; Wang, Y.; Landers, M. A.; Scher, H. I.
Abstract Title: Changes in CTC burden and prevalence of specific CTC subtypes in mCRPC patients (pts) receiving alpharadin (Ra-223) as single agent or in combination with other therapuetics (Tx)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 281s
Language: English
ACCESSION: WOS:000411931703065
DOI: 10.1200/JCO.2017.35.15_suppl.5076
PROVIDER: wos
Notes: Meeting Abstract: 5076 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Martin Fleisher
    303 Fleisher
  2. Howard Scher
    1079 Scher
  3. Jerry Seok Lee
    3 Lee